| Cardinal to Buy Healthcare Solutions Cardinal Health agreed to acquire Healthcare Solutions, a privately owned specialty-pharmaceutical company, for at least $517 million. online.wsj.com |
Celera Corporation Q2 2010 Earnings Call Transcript Celera Corporation (CRA)Q2 2010 Earnings Call TranscriptAugust 3, 2010 4:30 pm ETComplete Story » seekingalpha.com |
China Nuokang 2Q profit rises 10 pct to $2.9M (AP) China Nuokang Bio-Pharmaceutical Inc., which specializes in blood and cardiovascular treatments, said its second-quarter profit climbed 10 percent, as sales from its leading product helped boost revenue. us.rd.yahoo.com |
ERT to Announce Third Quarter 2010 Results on November 4, 2010 [PR Newswire] - ERT announced today that it will release its results for the third quarter 2010 on Thursday, November 4, 2010, after the market closes. After the release, the Company will host a conference call at 5:00 PM EDT that day. us.rd.yahoo.com |
Drug Development Spotlight: The mTOR's New Clothes? Michael Becker submits:In 1837, Hans Christian Andersen authored a short tale titled The Emperor’s New Clothes. The main character, so enamored by his appearance and his clothing that he had a different suit for every hour of the day, was swindled by a pair of weavers purporting that they could create clothing from a magical fabric that would only be visible to those who were completely pure in heart and spirit. However, when the Emperor parades before his subjects in the new outfit, a child cries out “But he isn’t wearing anything at all!” The Emperor had no clothes. The tale seems fitting to illustrate the evolution of drugs that target the phosphatidylinositol 3-kinase [PI3K] pathway [see Table 2 for a listing of compounds in clinical development]. Despite ample evidence that pan-PI3K inhibitors and dual PI3K/mTOR inhibitors might offer a therapeutic advantage, tailors continue to weave new compounds targeting individual components of the pathway with presumably superior properties. But does the “mTOR” really have new clothes?Complete Story » seekingalpha.com |